The YGC's Hiring Brief – Your Gateway to Biotech's Newest Opportunities | September 12, 2025

This isn’t scraped content. Every role here is vetted through YGC’s insider network — these are the opportunities that actually move careers forward.

The job market moves fast. Your career should move faster.

Each week, we curate the hottest roles in rare disease, gene therapy, oncology, and specialty biopharma — not scraped lists, but insider intel vetted through our network. These are the opportunities that matter: high-impact roles at lean, growing companies where disruption creates opportunity.

While others are slowing down, the real moves are happening now — here are the roles worth your attention.

This Week’s Featured Roles

High-Impact Commercial Roles Hiring Right Now in Rare Disease, Gene Therapy, Oncology & Specialty Biopharma

All jobs are active listings at powerful mission-driven teams. Check them out!

Rare Disease

Associate Director, Patient Marketing & Engagement — argenx

  • Company Momentum: argenx is riding the wave of VYVGART's commercial success, with the first-in-class neonatal Fc receptor blocker approved for generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP)

  • Market Opportunity: Targeting dozens of severe autoimmune diseases with a revolutionary mechanism of action

  • Career Growth: Leading HCP strategy for a transformative rare disease therapy in a rapidly expanding company

Head of Market Access & Patient Services — Dyne Therapeutics

  • Company Intelligence: $3.5B Market Cap with groundbreaking FORCE™ platform technology

  • FDA Breakthrough Therapy Designation for DYNE-251 in Duchenne muscular dystrophy

  • Pipeline Catalyst: DYNE-251 showing unprecedented dystrophin expression levels, targeting BLA submission in early 2026

  • Strategic Timing: Market access leadership during commercial transition phase offers exceptional career leverage

Field Reimbursement Manager, North Central — Alnylam

  • Market Position: RNAi Leader: Established platform with multiple approved therapies for rare diseases

  • Reimbursement Expertise: Critical role managing complex payer relationships for high-cost rare disease therapies

  • Geographic Advantage: South Central territory coverage offers broad market exposure

Rare Disease Account Manager, Birmingham — Calliditas

  • Niche Positioning: Specialized Focus: Dedicated rare disease commercial strategy for TARPEYO, the first FDA-approved treatment for IgA nephropathy

  • Regional Leadership: Alabama territory management for emerging rare disease therapies

  • Growth Market: Expanding rare disease treatment landscape in nephrology

Gene Therapy

SVP Market Access— uniQure

  • Gene Therapy Leadership: This is a chance to launch an industry-defining product in a white space market, shaping a new standard for ultra-rare CNS diseases

  • Build From Scratch: The SVP will recruit talent, foster culture, and design organizational strategy from launch onward—a rare opportunity to own blueprint-level work

  • Pivotal Impact: You'll collaborate frequently with C-suite and board, impacting uniQure's organizational trajectory at a transformative time

  • Compensation and Growth: SVP roles in gene therapy offer competitive packages, equity, and direct visibility to future CEO paths

Vice President, US Marketing — uniQure

  • Why It's Attractive: Frontline Leadership: Direct access to regional teams at launch, bridging strategy and real-world execution

  • Rare Disease Commercialization: Uniquely focused on selling specialty therapies to treatment centers—high visibility and impact

  • Talent Builder: Influence the next generation of sales/account leadership, fostering a culture of excellence and collaboration

Director, New Product Planning — uniQure

  • Cross-Functional Opportunity: Portfolio Shaper: Directly influences which gene therapy assets move forward, impacting future company growth

  • Strategic Exposure: Collaborates deeply with R&D, clinical, regulatory, commercial, and BD—all the decision-makers in biotech product development

  • Innovation Environment: Ideal for commercial leaders who thrive in high-growth, science-driven settings where new launches are routine

Care Coordinator, Patient Care Navigation — Krystal Biotech

  • Mission-Driven: Direct patient impact for ultra-rare, previously untreatable conditions with VYJUVEK®, the first redosable gene therapy

  • Biotech Growth: Become part of a company pioneering redosable gene therapy for dystrophic epidermolysis bullosa

  • Patient-Centric Role: Coordinate and organize administrative tasks to ensure smooth delivery of gene therapy services

Oncology

Director of Oncology Marketing — Natera

  • Strategic Impact: This is a hands-on leadership role where you drive go-to-market for flagship genomic products—directly shaping physicians' and payers' perceptions and supporting the launch of next-generation technologies

  • Cross-Functional Collaboration: You'll work with medical, commercial, product, and data science teams—a rare chance to inform nearly every aspect of the business and influence how complex science is marketed to multiple stakeholders

  • Innovation Focus: Leading marketing efforts for comprehensive genomic profiling and MRD testing platforms

Area Business Director, Northeast — Revolution Medicines

  • Growth Company: Prominent leadership at a company with first-in-class oncology focus targeting RAS-addicted cancers

  • Leadership: High influence in territory go-to-market strategy and team mentoring across 8 Sales Representatives

  • Geographic Coverage: Illinois, Iowa, Minnesota, South Dakota, North Dakota, Montana, Nebraska, Wyoming, Idaho, Utah, and partial coverage of Washington, Missouri, Indiana, Kansas

Uro Oncology Business Manager, Pittsburgh — ImmunityBio

  • Commercial Launch: Drive clinical conviction of Anktiva for early-stage bladder cancer patients

  • Strategic Territory: Pittsburgh territory management with focus on LUGPA clinics, Academic institutions, and IDN Hospitals

  • Breakthrough Innovation: Working with next-generation treatments for cancer and infectious diseases

Your Competitive Edge, Delivered Weekly

This round-up extends our newsletter's proven approach: quality over quantity, insight over information. While job aggregators throw hundreds of listings at you, we deliver the 10-15 opportunities each week that actually matter for your career trajectory.

Because in biotech, it's not about finding a job – it's about finding the right opportunity at the right time with the right company that positions you for the next decade of your career.

Ready to get ahead while others are standing still?

Don't miss a single opportunity. Subscribe to our newsletter delivered directly to your inbox every Friday, now improved with this special list of handpicked roles you don’t want to miss.

Stay Visible,

The YGC Team

Next
Next

Welcome to The YGC's Hiring Brief – Your Gateway to Biotech's Newest Opportunities | August 29, 2025